Volume 25, Number 6—June 2019
Research
Assessment of Economic Burden of Concurrent Measles and Rubella Outbreaks, Romania, 2011–2012
Table 5
Estimated overall cost per case of measles, rubella, or congenital rubella syndrome during concurrent outbreaks, Romania, 2011–2012*
Cost type |
Cost per case (sensitivity analysis lower bound–upper bound; 2013 US $) |
||
---|---|---|---|
Measles |
Rubella, not CRS |
CRS |
|
Household direct medical and nonmedical | $71 ($21–$127) | $19 ($6–$46) | NA |
Household indirect | $63 ($47–$86) | $42 ($34–$57) | NA |
Healthcare provider | $264 ($237–290) | $27 ($25–30) | NA |
National outbreak response | $42 ($37–46) | $42 ($38–47) | NA |
CRS cases direct medical | NA | NA | $4,820 ($1,742–$7,191) |
CRS cases lifetime discounted indirect | NA | NA | $39,231 (UB: $80,195) |
Estimated total societal/case | $439 ($389–494) | $132 ($118–$158) | $44,051 ($40,973–$85,015) |
*CRS, congenital rubella syndrome; NA, not applicable; UB, upper bound of sensitivity analysis.
1Current affiliation: JoDon Consulting Group LLC, Atlanta, Georgia, USA.
2Current affiliation: Centers for Disease Control and Prevention, Atlanta, Georgia, USA.